Pancragen — Reference, Dosing & Cited Studies

What it is

Pancragen (KEDW; Lys-Glu-Asp-Trp) is a short peptide bioregulator associated with pancreatic function, insulin and C-peptide dynamics, glucose metabolism, and age-related metabolic research.

Mechanism of action

Pancragen is studied for tissue-specific regulation of pancreatic cell function and differentiation during aging, including endocrine pancreatic markers and glucose-metabolism support.

Evidence summary

Evidence includes old-monkey endocrine-function work, elderly type 2 diabetes reports, and peptide bioregulator differentiation studies. Treat as educational research support rather than a replacement for diabetes care.

Pantheon dosing guide

Application: Subcutaneous injection.
BAC Water: 2 ml
Dose: 500 mcg-1 mg (5-10 units)
Frequency & Cycle Length: Daily for 10-20 days. Repeat 1-3 times yearly as needed.
Timing: Morning, ideally before food.
Key Benefits: Supports pancreatic function. Supports healthy glucose metabolism. Supports insulin and C-peptide signaling. Promotes metabolic balance.

Additional research protocol context

The printed guide above is Pantheon's dosing reference. These broader research examples are provided as context and may use different schedules.

20 mg vial reconstituted with 2.0 ml bacteriostatic water
500 mcg-1 mg subcutaneous daily
10-20 day courses; morning before food is most common

Side effects & safety

Injection-site redness, tenderness, itching, or mild swelling
Headache, nausea, lightheadedness, or digestive changes
Customers using glucose-lowering medications should consult a clinician before use

Cited studies

Disclaimer

All content is for research and educational purposes. Peptides described are sold for laboratory research use only and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before beginning any protocol.